Status:
COMPLETED
Epidemiology and Long-term Outcome of Patients With VHD
Lead Sponsor:
Medical University of Bialystok
Conditions:
Valvular Disease
Valvular Heart Disease
Eligibility:
All Genders
18+ years
Brief Summary
Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy. ...
Detailed Description
Valvular heart diseases are significant problem in Polish population. Coexistence of coronary artery disease in patients with VHD increases the risk of death and affects further therapeutic strategy. ...
Eligibility Criteria
Inclusion
- Valvular heart disease in moderate and severe stages
Exclusion
- Age \< 18 years old
Key Trial Info
Start Date :
January 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 1 2022
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT04527367
Start Date
January 1 2006
End Date
January 1 2022
Last Update
January 21 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Invasive Cardiology, Medical University of Bialystok, The Medical University of Bialystok Clinical Hospital
Bialystok, Poland, 15-276